sale y/i pf exceed our/street
estim csi slightli higher oper margin slightli
think lower gm ep beat our/street lower tax
rate sale guidanc cc street previou
owe headwind includ myday suppli constraint pre-
buy occur ahead japan vat increas paragard
ahead price increas ep guidanc vs consensu previou
increment invest misight anticip myday expans
follow recent misight myopia len fda approv management laid initi sale
ramp primari gate factor education/train certif
optometrist
/csi grew led silicon hydrogel clariti/myday
multifoc increment buy japan ahead vat increas
within csi growth led fertil offic surgic
led endose adopt paragard growth tough comp
saw pre-buy ahead price increas
misight remind fda approv misight indic slow myopia
nearsighted progress children age misight sale ou
target sale us expect sale
grow us respect focu near-
term educ activ physician famili launch target
dynam management note neg affect myday suppli
expect improv start japan sale pull-forward ahead
vat increas csi growth also expect full-year owe
pull-forward paragard sale
invest plan invest
misight includ clinical/regulatori invest global well sales/
market educ support patient clinician consist training/
certif process addit myday demand solid focus
increas product expect capac expans take place throughout
capital-expenditure expect remain elev
estim lower sale cc y/i
dynam note ep estim move lower y/i
lower gross margin assumpt capac expans effort
ep impact forecast sales/ep
year price histori
cooper compani global
medic devic compani focus
primarili
develop
market soft contact lens
compani also market varieti
surgic instrument
analyst certif import disclosur see disclosur
grow ahead market constant currenc
misight sale
oper margin y/i includ increment capac
len market grow next five year
competit stiffen contact len market
estim above-market contact len growth driven
compani specialti len offer increas silicon
contribut forecast
mid-single-digit medium-term sale growth paragard
rate share perform valuat
misight launch march
impact paraguard channel invest
misight ramp ahead expect
upsid paragard channel invest
better expect margin expans
larger impact competitor product rollout
lower expect gross margin leverag
price target impli approxim multipl calendar ep estim slightli ahead peer group current-trail
risk includ daili market growth slow competit increas lower expect gross margin leverag
non single-us sphere
non single-us sphere
